PTC Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
50.00
|
|
Average Rating
|
3.67
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
6
|
|
# Sells
|
2
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.24
|
-1.53
|
-0.29
|
-23.39%
|
|
2022-06-30
|
-1.33
|
-2.13
|
-0.80
|
-60.15%
|
|
2022-03-31
|
-1.51
|
-1.78
|
-0.27
|
-17.88%
|
|
2021-12-31
|
-1.64
|
-2.03
|
-0.39
|
-23.78%
|
|
2021-09-30
|
-1.49
|
-1.89
|
-0.40
|
-26.85%
|
|
2021-06-30
|
-1.82
|
-1.68
|
0.14
|
7.69%
|
|
2021-03-31
|
-1.51
|
-1.83
|
-0.32
|
-21.19%
|
|
2020-12-31
|
-0.94
|
-1.08
|
-0.14
|
-14.89%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-5.44
|
|
2021-12-31
|
-7.43
|
|
2020-12-31
|
-6.70
|
|
2019-12-31
|
-4.47
|
|
2018-12-31
|
-2.69
|
|
2017-12-31
|
-2.08
|
|
2016-12-31
|
-4.17
|
|
2015-12-31
|
-5.06
|
|
2014-12-31
|
-3.21
|
|
2013-12-31
|
-6.45
|